Zepbound and Mounjaro are Eli Lilly's name brands of tirzepatide
Behavioral choice treatment promotes continuing weight loss: preliminary results of a cognitive-behavioral decision-based treatment for obesity
Weeks 1-4: 0.25 mg semaglutide + 5-10 mg pyridoxine, injected subcutaneously once weekly Weeks 5-8: 0.5 mg semaglutide + 5-10 mg pyridoxine, injected subcutaneously once weekly Weeks 9-12: 1.0 mg semaglutide + 5-10 mg pyridoxine, injected subcutaneously once weekly Weeks 13-16: 1.7 mg semaglutide + 5-10 mg pyridoxine, injected subcutaneously once weekly Week 17 and beyond: 2.4 mg semaglutide + 5-10 mg pyridoxine, injected subcutaneously once weekly Some providers modify this schedule based on individual tolerance
Nutritional Information Ingredients: cla (conjugated linoleic acid) powder, bulking agent: microcrystalline cellulose, l-carnitine tartrate, camellia sinensis green tea extract, capsule shell (gelatine), anti-caking agents: silicon dioxide, magnesium salts of fatty acids
It is not yet approved in the UK or anywhere else
By following these guidelines, you can make the best decision to keep yourself safe and ensure the medication remains effective